Synonyms Complex dyslipidemia (disorder), Complex dyslipidemia |
Introduction- |
Target |
Mechanism PCSK9 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. EU [+3] |
First Approval Date17 Jul 2015 |
Target- |
Mechanism- |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism PCSK9 inhibitors |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Jun 2023 |
Sponsor / Collaborator |
Start Date01 Jan 2022 |
Sponsor / Collaborator |
Start Date12 Oct 2021 |
Sponsor / Collaborator |